ProfileGDS4814 / ILMN_1724907
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 93% 93% 93% 92% 93% 94% 92% 93% 92% 92% 93% 93% 92% 93% 94% 93% 93% 93% 94% 93% 93% 93% 93% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)600.64393
GSM780708Untreated after 4 days (C2_1)616.86793
GSM780709Untreated after 4 days (C3_1)622.74193
GSM780719Untreated after 4 days (C1_2)547.11392
GSM780720Untreated after 4 days (C2_2)659.19393
GSM780721Untreated after 4 days (C3_2)748.72894
GSM780710Trastuzumab treated after 4 days (T1_1)540.91892
GSM780711Trastuzumab treated after 4 days (T2_1)600.25193
GSM780712Trastuzumab treated after 4 days (T3_1)543.25892
GSM780722Trastuzumab treated after 4 days (T1_2)575.59692
GSM780723Trastuzumab treated after 4 days (T2_2)610.14393
GSM780724Trastuzumab treated after 4 days (T3_2)603.0193
GSM780713Pertuzumab treated after 4 days (P1_1)562.69692
GSM780714Pertuzumab treated after 4 days (P2_1)634.94193
GSM780715Pertuzumab treated after 4 days (P3_1)688.60394
GSM780725Pertuzumab treated after 4 days (P1_2)588.09693
GSM780726Pertuzumab treated after 4 days (P2_2)629.13493
GSM780727Pertuzumab treated after 4 days (P3_2)597.66693
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)723.32494
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)623.53893
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)672.22793
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)669.25893
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)655.55593